Results 271 to 280 of about 4,150,951 (316)
Olfactory Impairment and Incident Cognitive Decline: A Systematic Review and Meta‐Analysis
ABSTRACT Background Olfactory impairment (OI) is associated with poor ageing outcomes. While cross‐sectional studies found a high prevalence of OI among patients with neurodegenerative diseases, the temporal relationship remains unclear. This meta‐analysis aims to synthesise the longitudinal association of OI with cognitive decline (CD). Methods PubMed,
Brian Sheng Yep Yeo+17 more
wiley +1 more source
Nonsteroidal anti-inflammatory drug "allergy" labeling is associated with increased postpartum opioid utilization. [PDF]
Li L+5 more
europepmc +1 more source
A Case of Mediterranean Spotted Fever Misdiagnosed as Drug Allergy
Süda Tekin+2 more
openalex +2 more sources
Summary 1 versus 0 PDs within 90 days of initial ESS was associated with 11% decreased risk of revision ESS. 2 versus 1 PD or a first PD 8–30 versus 1–7 days after initial ESS did not affect risk of revision ESS. 3+ versus 1 PD or a first PD 31–90 versus 1–7 days after initial ESS was associated with increased risk of revision ESS.
Max J. Hyman+3 more
wiley +1 more source
ABSTRACT Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms that arise from neuroendocrine cells and commonly originate in the GI tract, lungs, and pancreas, but can also present in the skull base and paranasal sinuses. While fluorodeoxyglucose positron emission tomography (FDG PET) scans are routinely used in the evaluation of ...
Michael Sabbaj+12 more
wiley +1 more source
Key Points Elezanumab accelerates olfactory sensory neuron regeneration in a methimazole‐induced mouse model. Repulsive guidance molecule A blockade increases GAP43+ and OMP+ cells dorsally while sparing basal cells. This approach offers a novel therapy for sensorineural olfactory disorder.
Eri Mori+6 more
wiley +1 more source